Welcome to LookChem.com Sign In|Join Free

CAS

  • or

191034-03-4

191034-03-4

Post Buying Request

191034-03-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

191034-03-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 191034-03-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,0,3 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 191034-03:
(8*1)+(7*9)+(6*1)+(5*0)+(4*3)+(3*4)+(2*0)+(1*3)=104
104 % 10 = 4
So 191034-03-4 is a valid CAS Registry Number.

191034-03-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-[1-(4-fluorophenyl)-2-hydroxyethyl]piperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names 4-[1-(4-FLUORO-PHENYL)-2-HYDROXY-ETHYL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:191034-03-4 SDS

191034-03-4Downstream Products

191034-03-4Relevant articles and documents

Dual NK1 antagonists - Serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives

Ryckmans, Thomas,Berton, Olivier,Grimee, Renee,Kogej, Thierry,Lamberty, Yves,Pasau, Patrick,Talaga, Patrice,Genicot, Christophe

, p. 3195 - 3198 (2007/10/03)

The synthesis, structure-affinity relationship and activity of benzyloxyphenethyl piperazine derivatives combining NK1 antagonism and serotonin reuptake inhibition is described. Compound 7u was shown to be active in animal models of 5-HT reuptake inhibition and central NK1 receptor blockade, and was demonstrated to be orally active in an integrated model sensitive to both mechanisms. This class of compounds potentially represents a new generation of antidepressants.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 191034-03-4